Scientific News
A review: therapeutic potential of adipose- derived stem cells in cutaneous wound healing and regenaration
Read More » August 8, 2022
The Swiss Biotech company
leader on Stem Cells storage
Laboratories of property, more than 15 years of activity, FACT-NetCord accredited and GMP certified
This is the corporate website of SSCB – Swiss Stem Cell Biotech. If you are pregnant and you want to preserve stem cells please visit our national websites for all the information – Click here
SSCB - SWISS STEM CELLS BIOTECH
SSCB was founded in 2005 by a group of forward-looking researchers and physicians working at the Cardiocentro Ticino in Lugano (Switzerland). Since the first stem cell transplantation following a heart attack in 2004, people have been convinced that stem cells are the future of medicine. Thus it was known that the umbilical cord is a rich source of stem cells that could become a great resource for the future of the newborn.
Our Services
We provide international quality Services
Cord blood and cord tissue storage
Adipose derived stem cells (ADSCs) storage
DNA storage
Why choose SSCB?
Because we are really a realiable biobank
Our stem cell bank.
We guarantee complete control over all processes of cryopreservation, from processing in the laboratory to storage in our cryotanks. This enables you to know the status of your sample at any time.
Research
Choose with us a bank that is committed to exploring new frontiers in medicine.
Public and private banks
Due to our high-quality standards, we work together as a hybrid bank (public/private) with the Bern Hospital.
FACT-NetCord certification
This is an important international certification, the only one dedicated exclusively to umbilical cord banks. The achievement and maintenance of this certification requires repeated checks by the supervisory body.
GMP certification
This accreditation implies the respect of high quality standards; our products have the same quality level of pharmaceutical ones.
SWISSMEDIC
Authorised by the Swiss public health authorities, including Swissmedic.
Scientific and company news
Scientific News
Human mesenchymal stem cell treatment
of premature ovarian failure: new
challenges and opportunities
Read More » August 1, 2022
